Cited by 237Schizophrenia research and treatmentPsychological Testing and AssessmentDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.

Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial

Keefe, Richard S.E., Fox, Kolleen Hurley, Harvey, Philip D., Cucchiaro, Josephine, Siu, Cynthia, Loebel, Antony·2011·Schizophrenia Research

DOI 10.1016/j.schres.2010.09.015

Open this paper in CoChat — free account

Abstract

Objective The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Project produced a battery of tests, the MATRICS Consensus Cognitive Battery (MCCB), designed to assess cognitive treatment effects in clinical trials of patients with schizophrenia. In validation studies, the MCCB demonstrated excellent reliability, minimal practice effects and significant correlations with measures of functional capacity. This study addresses whether the MCCB demonstrates these favorable characteristics when administered in the context of the type of large multi-site industry trial for which it was designed.Methods In a clinical trial comparing risperidone and lurasidone, 323 clinically-stable outpatients with schizophrenia at 29 sites were assessed with MCCB at screening and a median of 15days later at baseline. A measure of functional capacity, the UCSD Performance-based Skills Assessment-Brief (UPSA-B) was administered at baseline.Results All 323 (100%) patients had sufficient data for computing a composite score according to the MCCB criteria. The test-retest reliability of the MCCB composite score was excellent (ICC=0.88). The severity of cognitive impairment was T=24.7 (SD=12.1) at screening and T=26.7 (SD=12.4) at baseline. The MCCB composite score demonstrated a large correlation with the UPSA-B composite score (r=.60, df=304, p<.001). The practice effect on the composite score was small (z=0.18).Discussion In the context of a 29-site antipsychotic trial in stable outpatients with schizophrenia, the MCCB is sensitive to cognitive deficits in all domains, demonstrates excellent test-retest reliability and small practice effects, and is strongly correlated with a leading measure of functional capacity.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2010.09.015

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., Essock, S., Fenton, W. S., Frese, F. J., Gold, J. M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010042 · Cited by 2,342
Self-citation
Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria
Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., Fenton, W. S., Frese, F., Goldberg, T. E., Heaton, R. K., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.023 · Cited by 919
Self-citation
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
Kern, R. S., Nuechterlein, K. H., Green, M. F., Baade, L. E., Fenton, W. S., Gold, J. M., Keefe, R. S. E., Mesholam-Gately, R., Mintz, J., Seidman, L. J., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010043 · Cited by 744
Self-citation
Statistical power analysis for the behavioral sciences
Sockloff, A. L. (1978) · Evaluation and Program Planning · doi:10.1016/0149-7189(78)90080-0 · Cited by 715
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi020 · Cited by 438
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426
Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia
Goldberg, T. E., GOLDMAN, R. S., Burdick, K. E., Malhotra, A. K., Lencz, T., Patel, R. C., Woerner, M. G., Schooler, N. R., Kane, J. M., & Robinson, D. G. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1115 · Cited by 396
Development of a Brief Scale of Everyday Functioning in Persons with Serious Mental Illness
Mausbach, B. T., Harvey, P. D., Goldman, S. R., Jeste, D. V., & Patterson, T. L. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm014 · Cited by 381
Self-citation

Flagged first, then by citations

Show all 17 references

1 of the 17 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 237

Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults
Chou, H., Talledo, J., Lamb, S. N., Thompson, W. K., & Swerdlow, N. R. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2948-x · Cited by 24
Cognitive training at home in schizophrenia is feasible
Ventura, J., Wilson, S. A., Wood, R. C., & Hellemann, G. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.033 · Cited by 22
Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review
Zoupa, E., Bogiatzidou, O., Siokas, V., Liampas, I., Tzeferakos, G., Mavreas, V. G., Stylianidis, S., & Dardiotis, E. (2022) · Neurology International · doi:10.3390/neurolint15010002 · Cited by 25
Development and testing of a web-based battery to remotely assess cognitive health in individuals with schizophrenia
Biagianti, B., Fisher, M., Brandrett, B. D., Schlosser, D. A., Loewy, R. L., Nahum, M., & Vinogradov, S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.047 · Cited by 23
Towards remote digital phenotyping of cognition in schizophrenia
Guimond, S., Keshavan, M. S., & Torous, J. B. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.04.016 · Cited by 21
Web-Based Cognitive Testing in Psychiatric Research: Validation and Usability Study
Lynham, A. J., Jones, I. R., & Walters, J. (2022) · Journal of Medical Internet Research · doi:10.2196/28233 · Cited by 18
Epigenetic Targets in Schizophrenia Development and Therapy
Wawrzczak‐Bargieła, A., Bilecki, W., & Maćkowiak, M. (2023) · Brain Sciences · doi:10.3390/brainsci13030426 · Cited by 25
Psychedelics action and schizophrenia
Maćkowiak, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00546-5 · Cited by 22
Transdiagnostic neurocognitive dysfunction in children and adolescents with mental illness
Hilton, R. A., Tozzi, L., Nesamoney, S., Kozlowska, K., Kohn, M. R., Harris, A. W. F., Clarke, S. P., & Williams, L. M. (2024) · Nature Mental Health · doi:10.1038/s44220-023-00199-6 · Cited by 19
Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder
Harvey, P. D., Jacobson, W., Zhong, W., Nomikos, G. G., Christensen, M. C., Olsen, C. K., & Merikle, E. P. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.014 · Cited by 19
Self-citation
A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia
Arce, E., Balice‐Gordon, R. J., Duvvuri, S., Naylor, M., Xie, Z., Harel, B., Kozak, R., Gray, D. L., & DeMartinis, N. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855302 · Cited by 18
Placebo Effects Across Self-Report, Clinician Rating, and Objective Performance Tasks Among Women With Post-Traumatic Stress Disorder
Hodgins, G. E., Blommel, J. G., Dunlop, B. W., Iosifescu, D. V., Mathew, S. J., Neylan, T. C., Mayberg, H. S., & Harvey, P. D. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000858 · Cited by 20
Self-citation
Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery
Bezdíček, O., Michalec, J., Kališová, L., Kufa, T., Děchtěrenko, F., Chlebovcová, M., Havlík, F., Green, M. F., & Nuechterlein, K. H. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.004 · Cited by 20
Face perception in schizophrenia: a specific deficit
Megreya, A. M. (2016) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2015.1133407 · Cited by 17
Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia)
Araújo, G. E., Brandão‐de‐Resende, C., Cardoso, A. C. A., Teixeira, A. L., Keefe, R. S. E., & Salgado, J. V. (2015) · Clinics · doi:10.6061/clinics/2015(04)10 · Cited by 17
Self-citation
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
Keefe, R. S. E., Harvey, P. D., Correll, C. U., Falkai, P., Hashimoto, N., Klein, H., Krystal, J. H., Marder, S. R., Medalia, A. A., Sumiyoshi, T., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00296-2 · Cited by 16
Self-citation
Cognition in Patients with Schizophrenia: Interplay between Working Memory, Disorganized Symptoms, Dissociation, and the Onset and Duration of Psychosis, as Well as Resistance to Treatment
Panov, G., Dyulgerova, S., & Panova, P. (2023) · Biomedicines · doi:10.3390/biomedicines11123114 · Cited by 20
Cognition, social cognition and functional disability in early-stage schizophrenia: A study from southern India
Kurtz, M. M., Gopal, S., John, S., & THARA, R. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.091 · Cited by 17
Development and Evaluation of a Visual Remediation Intervention for People with Schizophrenia
Seitz, A. R., Ahmed, A. O., Thompson, J. L., D.Butler, P., Silverstein, S. M., Gara, M. A., & Zemon, V. M. (2020) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20200017 · Cited by 16
Limited practice effects and evaluation of expectation for change: MATRICS Consensus Cognitive Battery
Roseberry, J. E., & Hill, S. K. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.08.004 · Cited by 15
Objective psychosocial function vs. subjective quality-of-life in schizophrenia within 5-years after diagnosis: A study from southern India
Kurtz, M. M., Gopal, S., John, S., & THARA, R. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.149 · Cited by 15
Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study
Guo, J. Y., Niendam, T. A., Auther, A. M., Carrión, R. E., Cornblatt, B. A., Ragland, J. D., Adelsheim, S. N., Calkins, R., Sale, T. G., Taylor, S. F., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291719002332 · Cited by 17
An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia
Kumar, S., Mulsant, B. H., Tsoutsoulas, C., Ghazala, Z., Voineskos, A. N., Bowie, C. R., & Rajji, T. K. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4547 · Cited by 14
Practice Effects and Test–Retest Reliability of the Continuous Performance Test, Identical Pairs Version in Patients with Schizophrenia over Four Serial Assessments
Chen, K., Lin, G., Chen, N.-C., Wang, J.-K., & Hsieh, C. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa004 · Cited by 14
Screening for cognitive impairment in schizophrenia: Psychometric properties of the German version of the Screen for Cognitive Impairment in Psychiatry (SCIP-G)
Sachs, G., Lasser, I., Purdon, S. E., & Erfurth, A. (2021) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2021.100197 · Cited by 14
Déficit cognitivo en la esquizofrenia: MATRICS Consensus Cognitive Battery
Rodríguez–Jiménez, R., Bagney, A., Moreno-Ortega, M., García-Navarro, C., Aparicio, A. I., López‐Antón, R., de la Oliva, J., Arriero, M. Á. J., Santos, J. L., Lobo, A., et al. (2012) · Revista de Neurología · doi:10.33588/rn.5509.2012246 · Cited by 14
Can genetics inform the management of cognitive deficits in schizophrenia?
Vyas, N. S., Shamsi, S. A. R., Malhotra, A. K., Aitchison, K. J., & Kumari, V. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111434623 · Cited by 14
People with schizophrenia do not show the normal benefits of social versus nonsocial attentional cues.
Catalano, L. T., Green, M. F., Wynn, J. K., & Lee, J. (2020) · Neuropsychology · doi:10.1037/neu0000642 · Cited by 15
Do clinical characteristics predict the cognitive course in early‐onset schizophrenia‐spectrum disorders?
Teigset, C. M., Mohn, C., Brunborg, C., Juuhl‐Langseth, M., Holmén, A., & Rund, B. R. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12896 · Cited by 13
Relation between functional and cognitive impairments in remitted patients with bipolar disorder and suggestions for trials targeting cognition: An exploratory study
Ott, C. V., Miné, H., Petersen, J. Z., & Miskowiak, K. W. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.030 · Cited by 13
Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study
Fu, S., Czajkowski, N. O., & Torgalsbøen, A. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.06.016 · Cited by 13
Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
Zhuo, C., Xu, Y. J., Wang, H., Fang, T., Chen, J., Zhou, C., Li, Q., Liu, J., Xu, S.-L., Yao, C., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.681418 · Cited by 12
Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
Blackman, R. K., Dickinson, D., Eisenberg, D. P., Gregory, M. D., Apud, J. A., & Berman, K. F. (2021) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2021.100223 · Cited by 12
Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning
Antonucci, L. A., Pergola, G., Rampino, A., Rocca, P., Rossi, A., Amore, M., Aguglia, E., Bellomo, A., Bianchini, V., Brasso, C., et al. (2022) · Psychological Medicine · doi:10.1017/s003329172200294x · Cited by 11
A ten-year longitudinal repeated assessment study of cognitive improvement in patients with first-episode schizophrenia and healthy controls: The Oslo Schizophrenia Recovery (OSR) study
Torgalsbøen, A., Mohn, C., Larøi, F., Fu, S., & Czajkowski, N. O. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.08.008 · Cited by 11
[MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
Jędrasik-Styła, M., Ciołkiewicz, A., Denisiuk, M., Linke, M., Parnowska, D., Gruszka, A., Jarema, M., & Wichniak, A. (2012) · PubMed · Cited by 11
Longitudinal determinants of client treatment satisfaction in an intensive first‐episode psychosis treatment programme
Cruz, L. N., Kline, E. R., Seidman, L. J., Minor, K. S., Meyer, E. C., Iati, C. A., Zimmet, S. V., & Friedman‐Yakoobian, M. S. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12323 · Cited by 11
Cognitive Impairment in Schizophrenia: Description and Cognitive Familiar Endophenotypes. A Review of the Literature
García-Laredo, E. (2018) · InTech eBooks · doi:10.5772/intechopen.78948 · Cited by 12
Cognitive gains as a mechanism of functional capacity improvement in schizophrenia: Results from a multi-site randomized controlled trial
Flores, A. T., Hogarty, S. S., Mesholam‐Gately, R. I., Barrio, C., Keshavan, M. S., & Eack, S. M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.05.016 · Cited by 11
Symptomatic thinking: the current state of Phase III and IV clinical trials for cognition in schizophrenia
Talpos, J. C. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.014 · Cited by 13
Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis
Dong, F., Mao, Z., Ding, Y., Wang, L., Bo, Q., Li, F., Wang, F., & Wang, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1292141 · Cited by 10
Biomarker discovery using machine learning in the psychosis spectrum
Yassin, W., Loedige, K. M., Wannan, C., Holton, K. M., Chevinsky, J. D., Torous, J. B., Hall, M., Ye, R. R., Kumar, P., Chopra, S., et al. (2024) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2024.100107 · Cited by 11
Impaired Verbal Learning Is Associated with Larger Caudate Volumes in Early Onset Schizophrenia Spectrum Disorders
Juuhl‐Langseth, M., Hartberg, C. B., Holmén, A., Thormodsen, R., Groote, I. R., Rimol, L. M., Emblem, K. E., Agartz, I., & Rund, B. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130435 · Cited by 11
Characteristics of cognitive impairment in schizophrenia
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.002 · Cited by 10
Self-citation
A pilot and feasibility study of computer-based training for visual processing deficits in schizophrenia
Surti, T. S., & Wexler, B. E. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.09.013 · Cited by 9
Cognition in schizophrenia: Summary Nice Consultation Meeting 2012
Nutt, D., Wied, C. C. G., Arango, C., Keefe, R. S. E., Penadés, R., Murphy, D., Robbins, T. W., & Sahakian, B. J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.005 · Cited by 9
Self-citation
Symptom contributors to quality of life in schizophrenia: Exploratory factor and network analyses
Murphy, S. M., Flores, A. T., Wojtalik, J. A., Keshavan, M. S., & Eack, S. M. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.01.028 · Cited by 8
Neurocognitive dysfunctions in childhood-onset schizophrenia: A systematic review
Armita, A., Guivarch, J., Dor, E., Laure, G., Zeghari, R., Gindt, M., Thümmler, S., Askenazy-Gittard, F., & Fernandez, A. (2025) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2024.100342 · Cited by 8
Construct validity of the UCSD performance-based skills assessment-brief version (UPSA-B) in HIV disease
Sheppard, D. P., Woods, S. P., Verduzco, M., & the HIV Neurobehavioral Research Center (HNRC) Group (2017) · Applied Neuropsychology Adult · doi:10.1080/23279095.2017.1341888 · Cited by 8
Effectiveness of the early intervention service for first-episode psychosis in Navarra (PEPsNa): Broadening the scope of outcome measures
de Jalón, E. G., Ariz, M. C., Unzue, A. A., Aranguren, L., Gutierrez, G., Corrales, A., Sánchez-Torres, A. M., Gil‐Berrozpe, G. J., Peralta, V., & Cuesta, M. J. (2022) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2022.07.002 · Cited by 8
Assessing Long-Term Test-Retest Reliability of the CPT-IP in Schizophrenia
Hahn, E. W., Vollath, A., Ta, T. M. T., Hahn, C., Kuehl, L. K., Dettling, M., & Neuhaus, A. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084780 · Cited by 7
Can neuroimaging-based biomarkers predict response to cognitive remediation in patients with psychosis? A state-of-the-art review
Biagianti, B., Bigoni, D., Maggioni, E., & Brambilla, P. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.03.006 · Cited by 6
Heterogeneity in Functional Connectivity: Dimensional Predictors of Individual Variability during Rest and Task fMRI in Psychosis
Secara, M. T., Oliver, L. D., Gallucci, J., Dickie, E. W., Foussias, G., Gold, J. M., Malhotra, A. K., Buchanan, R. W., Voineskos, A. N., & Hawco, C. S. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110991 · Cited by 6
The MATRICS consensus cognitive battery for the assessment of cognitive impairment in schizotypal personality disorder
Challman, K. N., Rosell, D. R., Barch, D. M., Koenigsberg, H. W., Harvey, P. D., Hazlett, E. A., Pérez-Rodríguez, M. M., New, A. S., & McClure, M. M. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.04.007 · Cited by 6
Self-citation
Grant Report on D-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †
de la Garrigue, N., Glasser, J., Sehatpour, P., Iosifescu, D. V., Dias, E. C., Carlson, M., Shope, C. B., Sobeih, T. M., Choo, T. H., Wall, M. M., et al. (2020) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20200018 · Cited by 6
Prevalence, correlates and explanatory models of cognitive deficits in patients with schizophrenia—A cross sectional study
Uppinkudru, C., Gopalakrishnan, R. M., Noel, J., & Kuruvilla, A. (2023) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_102_23 · Cited by 9
Development of a Virtual Reality Assessment of Everyday Living Skills
Ruse, S. A., Davis, V. G., Atkins, A. S., Krishnan, K. R. R., Fox, K. H., Harvey, P. D., & Keefe, R. S. E. (2014) · Journal of Visualized Experiments · doi:10.3791/51405-v · Cited by 6
Self-citation
Cognitive function at first episode in patients subsequently developing treatment-resistant schizophrenia
Aguirre, J. M., Dellarossa, C. D., Barbagelata, D., Núñez, J. V., Mena, C., Tepper, Á., Ramírez-Mahaluf, J. P., Aceituno, D., Nachar, R., Undurraga, J. P., et al. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.01.017 · Cited by 5
Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls
Guzman, A., Klein, H., Keefe, R. S. E., Horan, W. P., & Harvey, P. D. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116121 · Cited by 5
Self-citation
Differences in cognitive function and daily living skills between early- and late-stage schizophrenia
Kim, S.-J., Shim, J.-C., Kong, B.-G., Kang, J.-W., Moon, J., Jeon, D.-W., Seo, Y.-S., Oh, M., & Jung, D.-U. (2015) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2015.1084328 · Cited by 5
Methods for Delivering and Evaluating the Efficacy of Cognitive Enhancement
Harvey, P. D., & Keefe, R. S. E. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_1 · Cited by 5
Self-citation
Impairment in Emotional Intelligence May Be Mood-Dependent in Bipolar I and Bipolar II Disorders
Kuo, S.-Y., Chang, Y.-H., Wang, T., Tseng, H., Huang, C.-C. J., Chen, P. S., Lane, H., Yang, Y. K., & Lu, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.597461 · Cited by 5
Mobile cognitive remote assessment of schizophrenia: a global multi-site pilot study
Castillo, J., Cheong, J., Choudhary, S., Bondre, A. P., Rozatkar, A. R., Mehta, U. M., Shrivastava, R., Ahmad, M. A., Malviya, A., Sen, Y., et al. (2025) · Schizophrenia · doi:10.1038/s41537-025-00660-8 · Cited by 4
PsyCog: A computerised mini battery for assessing cognition in psychosis
Gifford, G., Cullen, A. E., Vieira, S., Searle, A., McCutcheon, R. A., Modinos, G., Stone, W. S., Hird, E., Barnett, J. H., van Hell, H. H., et al. (2024) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2024.100310 · Cited by 4
The awareness, characterization, and burden of Cognitive Impairment Associated with Schizophrenia (CIAS) in clinical practice: Results from a nationwide survey in Italy
Vita, A., Barlati, S., Cavallaro, R., Cipelli, R., Corrivetti, G., Delmonte, D., Lusito, E., Maia, E., Marino, M. M., Nicolò, G., et al. (2025) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2025.100352 · Cited by 4
Schizophrenia: Genetics, neurological mechanisms, and therapeutic approaches
Lim, D. X. E., Yeo, S. Y., Chia, Z. Y. A., Fernandis, A. Z., Lee, J., & Chua, J. J. E. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01375 · Cited by 9
Development and Evaluation of a Cognitive Battery for People With Schizophrenia in Ethiopia
Gebreegziabhere, Y., Habatmu, K., Cella, M., & Alem, A. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad178 · Cited by 4
Effects of Milnacipran on Neurocognition, Pain, and Fatigue in Fibromyalgia
Kim, J. L., Rele, S., Marks, D. M., Masand, P. S., Yerramsetty, P., Millet, R. A., Keefe, R. S. E., & Patkar, A. A. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13m01555 · Cited by 4
Self-citation
The Importance of Cognitive Processes for the Integrative Treatment of Persons with Schizophrenia
Pfammatter, M., Brenner, H. D., Junghan, U. M., & Tschacher, W. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr099 · Cited by 6
Gestational length affects neurocognition in early-onset schizophrenia
Teigset, C. M., Mohn, C., & Rund, B. R. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.07.017 · Cited by 4
Neurocognitive impairment in patients with comorbid diabetes mellitus and depression
Padilla, V. L., Rustad, J. K., Harvey, P. D., Wasserman, B., Ziemer, D. C., & Musselman, D. L. (2017) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2016.12.004 · Cited by 4
Self-citation
Schizophrenic patients’ cognitive functions in relation to their metabolic profile: a cross-sectional, comparative study on an Egyptian sample
Ali, D. H., Elserafi, D. M., Soltan, M. A. R., Eissa, M. F., Zein, H. A., & ElShahawi, H. H. (2020) · Middle East Current Psychiatry · doi:10.1186/s43045-020-00053-w · Cited by 4
Education Mediates Racial Disparities in Cognitive Impairment Among Older Adults With Schizophrenia
Dobbins, S. K., Hubbard, E. M., & Leutwyler, H. C. (2021) · Clinical Gerontologist · doi:10.1080/07317115.2021.1882021 · Cited by 4
Functional Connectivity of Language-Related Cerebellar Regions Is Reduced in Schizophrenia Patients
Marino, M., Biondi, M., Mantini, D., & Spironelli, C. (2024) · Biomedicines · doi:10.3390/biomedicines12030480 · Cited by 4
TRPV1 Suppresses Microglial Inflammatory Activation to Ameliorate Schizophrenia-Associated Behaviors in Maternal Separation Rats
Chen, F., Hao, K., Shu, C., Xiong, Y., Xu, R., Huang, H., Peng, B., Liu, Z., Reynolds, G. P., Wang, G., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf153 · Cited by 4
Splitting schizophrenia: divergent cognitive and educational outcomes revealed by genomic structural equation modelling
Watson, C. J., Zvrskovec, J., Merola, G. P., Gilchrist, L., Haussler, S. M., Schattner, M., Lo, C. W. H., Breen, G. D., Murray, R. M., Lewis, C. M., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03444-3 · Cited by 5
Application of cognitive behavioural therapy combined with aripiprazole in the treatment of schizophrenia: a randomised controlled trial
Yan, J., Li, K., He, Q., & Xiong, J. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2025.14 · Cited by 3
Effects of an extrinsic motivator on the evaluation of cognitive and daily living functions in patients with schizophrenia
Kim, S.-J., Jung, D.-U., Moon, J., Jeon, D.-W., Seo, Y.-S., Jung, S. S., Lee, Y.-C., & Kim, J. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.036 · Cited by 3
Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes
Selloni, A., Bhatia, G., Ranganathan, M., & Aquino, J. P. D. (2022) · Journal of Dual Diagnosis · doi:10.1080/15504263.2022.2053264 · Cited by 3
Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective
Williamson, D. J., Nuechterlein, K. H., Tishler, T. A., Ventura, J., Ellingson, B. M., Turkoz, I., Keefe, R. S. E., & Alphs, L. D. (2022) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2022.100270 · Cited by 3
Self-citation
A dismantling study of comprehensive cognitive remediation for improving employment outcomes: what is the role of computer cognitive training?
McGurk, S. R., Mueser, K. T., Xie, H., Bloch, P. P., DeTore, N. R., Pashka, N. J., Guarino, S., Ruiz, A., Elliot, C., Gagnon, H., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725100986 · Cited by 3
Kognitive Defizite bei Schizophren Erkrankten
Carolus, A. M., Popova, P., & Rockstroh, B. S. (2015) · Zeitschrift für Klinische Psychologie und Psychotherapie · doi:10.1026/1616-3443/a000288 · Cited by 3
Cognition as a predictor of social network size and early communication in clinically high risk for psychosis individuals
Linares, N. N., Pratt, D. N., Damme, K. S. F., & Mittal, V. A. (2025) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2025.100365 · Cited by 2
Effect of computerized cognitive remediation therapy combined with individualized occupational therapy on cognitive function and functional outcomes in patients with schizophrenia: A randomized controlled trial
Hu, G., Wei, D., Zhang, J., Liu, J., Liao, L., Zheng, L., Wu, X., Wu, X., Wei, B., & Wan, J. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116789 · Cited by 2
The impact of premature birth and low birth weight on motor, visual, and cognitive skills and mental health in adolescence: a systematic review and meta-analysis
Schröpfer, F., Greif, E., Eickhoff, S., Schewe, H., Wiese, J., Derner, N., Heller, L., Andreou, C., Rose, K., Obleser, J., et al. (2026) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-025-02937-w · Cited by 4
Cognitive Impairments Related to COMT and Neuregulin 1 Phenotypes as Transdiagnostic Markers in Schizophrenia Spectrum Patients
Bondrescu, M., Dehelean, L., Farcaş, S. S., Papavă, I., Nicoras, V., Podaru, C. A., Sava, M., Bilavu, E. S., Putnoky, S., & Andreescu, N. I. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216405 · Cited by 2
A novel digital intervention for improving cognitive impairment in patients with chronic schizophrenia: A randomized clinical trial
Xu, L., Yang, W., Fan, R., Wu, Y., Tang, Y., Zhang, R., & Yang, X. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.10.023 · Cited by 2
DIGITAL HEALTH TECHNOLOGIES IN THE PSYCHOSOCIAL TREATMENT OF CORE SYMPTOMS OF PSYCHOTIC DISORDERS — LITERATURE REVIEW AND PRACTICAL ASPECTS
Mikkonen, K., Wegelius, A., Salmijärvi, L., Paunio, T., & Kieseppä, T. (2020) · Työväentutkimus Vuosikirja · Cited by 2
Examination on the Acceptability, Feasibility and Effectiveness of a Digital Cognitive Training Software in Patients With Stable Schizophrenia in China
Yang, L., Tang, Y., Zhu, J., Xu, L., Wang, M., Sun, W., & Shi, C. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s497602 · Cited by 1
Pharmacological Activity of Scopoletin: Deciphering the Potential of Coumarins in Cognitive Dysfunction
Wal, P., Vadera, S., Aziz, N., Gupta, P., Rajesh, K. S., Rao, C. M. P., & Sharma, M. C. (2025) · Current Drug Research Reviews · doi:10.2174/0125899775358899250726213130 · Cited by 1
Interrelationships among oxidative stress, niacin response, cognition, and symptoms in chronic schizophrenia: a case-control study
Chen, L., He, J., Yuan, Y., Sun, C., Tian, Q., & Zhang, X. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07736-w · Cited by 1
Prospective memory, working memory, planning, and attention in schizophrenia and bipolar disorder: A comparative study
Yasmin, N., & Pandey, R. (2018) · Applied Cognitive Psychology · doi:10.1002/acp.3423 · Cited by 1
A group comparison in fMRI data using a semiparametric model under shape invariance
Samaddar, A., Jackson, B. S., Helms, C. J., Lazar, N. A., McDowell, J. E., & Park, C. (2021) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2021.107361 · Cited by 1
Theoretical Background
Schmidt, S. J., & Roder, V. (2015) · Springer eBooks · doi:10.1007/978-3-319-13245-7_1 · Cited by 1
Considering Medication Exposure in Genomic Association Studies of Cognition in Psychotic Disorders
Eum, S., Hill, S. K., & Bishop, J. R. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0070 · Cited by 1
Kognitive Beeinträchtigung in Zusammenhang mit Schizophrenie (CIAS): Diagnostik und Therapie
Sachs, G., & Erfurth, A. (2024) · psychopraxis neuropraxis · doi:10.1007/s00739-024-00986-5 · Cited by 1
Effect of Atypical Anti-psychotics on Cognition in Schizophrenia
Badr, M. Y., Shamah, G., Badawy, A. A. E.-K., Sabakhawy, A., & Eldeeb, F. A. (2024) · NILES Journal forGeriatric and Gerontology/NILES Journal for Geriatric and Gerontology · doi:10.21608/niles.2024.285074.1084 · Cited by 1
Commentary
Keefe, R. (2025) · Schizophrenia bulletin · doi:10.1093/schbul/sbae191 · Cited by 1
Self-citation
Assessment of the German Version of Brief Assessment of Cognition in Schizophrenia (BACS)
Mortazavi, M., Amon, J., Jäger, I. M., Hasanaj, G., Farsani, Z. A., Fischer, K., Gamer, M., Hasan, A., Keefe, R. S. E., Sachs, G., et al. (2025) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2025.100364 · Cited by 1
Self-citation
Recent developments in neuropsychological endophenotypes for schizophrenia: Development of the MATRICS battery, liability syndromes and the near future
Stone, W. S., & Hsi, X. (2011) · Chinese Science Bulletin · doi:10.1007/s11434-011-4759-6 · Cited by 1

Authors: Keefe, R. S. E., Fox, K. H., Harvey, P. D., Cucchiaro, J., Siu, C., & Loebel, A.
Affiliations: Duke University (US)
Verasci (United States) (US)
University of Miami (US)
Sunovion (United States) (US)
Corresponding author: Keefe, Richard S.E.
ORCID: Keefe, Richard S.E.
Harvey, Philip D.
Loebel, Antony
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 2011-02
Volume: 125
Issue: 2-3
Pages: 161-168
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/j.schres.2010.09.015
OpenAlex: W2169310695
Cited by: 237
References: 17
Citations by year: 2026: 14 · 2025: 25 · 2024: 15 · 2023: 11 · 2022: 15 · 2021: 9 · 2020: 12 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 13 · 2015: 16 · 2014: 22 · 2013: 20 · 2012: 14
FWCI: 10.03
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Schizophrenia Research (publishedVersion)
PubMed (publishedVersion)
Funders: GlaxoSmithKline
CHDI Foundation
H. Lundbeck A/S
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: MATRICS Consensus Cognitive Battery, schizophrenia
MeSH terms: Lurasidone Hydrochloride, Adult, Cognition Disorders, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology, Thiazoles, Antipsychotic Agents, Reproducibility of Results, Risperidone, Isoindoles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks